Orifarm is a pharmaceutical group headquartered in Odense, Denmark. Its website states that its mission is to “make as many people as possible have as healthy a day as possible.” Based on the crawled content, Orifarm primarily improves access to healthcare by supplying a wide range of medicines and health products to wholesalers, pharmacies, hospitals, and patients, including by sourcing medicines at lower cost and offering established household brands. The company discloses a scale of around 2,300 employees, 5 production sites, 12 sales offices, 16 sales markets, and 30 sourcing markets.
It should be made clear that the crawled content does not indicate that Orifarm offers SaaS or enterprise software products. Its “core capabilities” are closer to pharmaceutical supply chain and health product distribution, rather than software modules. The text does not mention enterprise software features such as project management, CRM, ERP, data analytics, automated workflows, team collaboration, permission management, third-party integrations, or API capabilities. The website only provides common corporate-site sections such as country/region selection, news, about us, careers, contact information, FAQ, publications, e-invoicing, privacy policy, and cookies.
The content does not provide any software plans, subscription pricing, free version, trial period, or billing model. As a result, it is not possible to assess its value for money as a SaaS product. There is also no information about deployment options such as cloud deployment, self-hosting, private deployment, or mobile apps. If users are looking for a purchasable software service, the current text does not demonstrate that Orifarm has such a product format.
The main advantage is that Orifarm operates across multiple countries and discloses a relatively clear group scale, along with contact information in Europe and the United States. This makes it useful for pharmaceutical supply chains, pharmacies, hospitals, and related channels that want to understand the company’s background. The downside is that, from a SaaS or enterprise software evaluation perspective, almost all key information is missing: there is no pricing, no trial, no integrations, no permission system, no API, no service support description, and no customer success or implementation delivery information.
Orifarm is better suited to pharmaceutical industry partners, drug wholesalers, pharmacies, hospitals, and organizations interested in the European pharmaceutical supply chain. It is not suitable as an enterprise software selection option. Access from China cannot be determined from the text, and payment methods are not disclosed. If Chinese companies are looking for alternatives, they should choose pharmaceutical distribution partners based on specific needs, or separately evaluate local ERP systems, pharmaceutical supply chain systems, pharmacy management systems, and similar software.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on orifarm.pl official site.
orifarm.pl is an Denmark SaaS Tools provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach orifarm.pl directly.